Amina Šeta, S. Dinarević-Mesihović, Timur Šečić, Miralem Đešević
{"title":"Unresolved symptoms in adult population after mild SARS-CoV2 infections","authors":"Amina Šeta, S. Dinarević-Mesihović, Timur Šečić, Miralem Đešević","doi":"10.48188/hczz.1.2.7","DOIUrl":null,"url":null,"abstract":"Introduction. The coronavirus disease (COVID-19) in the past year\nand a half has become a worldwide pandemic. COVID-19 symptoms, severity and\nduration vary widely, with an increasing number of cases of unresolved and\nprolonged symptoms.\nObjectives. This study aims to characterize unresolved\nsymptoms of mild COVID-19 patients for a period of five months after disease\nonset, and potentially aid in disease management.\nMethods. Seventy-five adult patients were involved in\nthe study in the period October 2020- March 2021 in Eurofarm Centre Private Healthcare.\nInclusion criteria required patients to be aged ≥18 years, with positive SARS-CoV2\nPCR test results and non-severe symptoms which did not require hospitalization.\nThe onset, duration and resolution of symptoms were analysed.","PeriodicalId":240055,"journal":{"name":"Hrvatski časopis zdravstvenih znanosti","volume":"19 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hrvatski časopis zdravstvenih znanosti","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.48188/hczz.1.2.7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction. The coronavirus disease (COVID-19) in the past year
and a half has become a worldwide pandemic. COVID-19 symptoms, severity and
duration vary widely, with an increasing number of cases of unresolved and
prolonged symptoms.
Objectives. This study aims to characterize unresolved
symptoms of mild COVID-19 patients for a period of five months after disease
onset, and potentially aid in disease management.
Methods. Seventy-five adult patients were involved in
the study in the period October 2020- March 2021 in Eurofarm Centre Private Healthcare.
Inclusion criteria required patients to be aged ≥18 years, with positive SARS-CoV2
PCR test results and non-severe symptoms which did not require hospitalization.
The onset, duration and resolution of symptoms were analysed.